NCT06029959Completed
Stroke and CPAP Outcome Study 3
Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation
Source: ClinicalTrials.gov · Last updated 8 Oct 2025
Brief summary (registry, in English)
A problem with breathing during sleep, called obstructive sleep apnea (OSA), likely increases the risk of stroke and is common in people who have had a stroke, present in about 2/3 of stroke survivors. There is also evidence that OSA predicts worse outcome after stroke. The question being addressed in the Stroke and CPAP Outcome Study 3 (SCOUTS3) is how to improve use of continuous positive airway pressure (CPAP) therapy to treat OSA when started during intensive stroke rehabilitation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 1 Sept 2023
- Start date
- 1 Oct 2023
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- University of Washington
- Diseases
- Stroke
- NCT number
- NCT06029959
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 1 Oct 2023 to the primary completion date, 30 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of positive airway pressure or use within 14 days prior to stroke
- Active use of sedative drugs that can interfere with testing for obstructive sleep apnea (OSA)
Other illness
- History of pneumothorax, bullous emphysema or other serious co-morbid conditions which limit CPAP use
- Stroke related to tumors, vascular malformations or subarachnoid hemorrhage
Other
- Unable to obtain informed consent from participant or surrogate
- Incarcerated
- Known pregnancy
- Current mechanical ventilation, tracheostomy or supplemental oxygen use \> 4L/min
- Anticipated inpatient rehabilitation length of stay \< 3 nights
Who the study is looking for
- Age 18 years or older
- Head CT or brain MRI demonstrating an acute ischemic infarction or intraparenchymal hemorrhage within past 30 days
- Person providing consent (patient or legally authorized representative) able to be consented in English or Spanish
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.